P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics

Menno V. Huisman; HC Diener; Sérgio Dubner; Jonathan L. Halperin; Kenneth J. Rothman; Changsheng Ma; Shihai Lu; Miney Paquette; Christine Teutsch; Lionel Riou França; Kristina Zint; Professor Gregory Lip

doi:10.1093/eurheartj/ehy563.p3862

Related publications

Article2022

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program

Lea Beier, Shihai Lu, Lionel Riou França, Sabrina Marler, Professor Gregory Lip, Menno V. Huisman, Christine Teutsch, Jonathan L. Halperin, Kristina Zint, Hans‐Christoph Diener, Laurie Baker, Changsheng Ma, Miney Paquette, Dorothee B. Bartels, Sérgio Dubner, Philippe Lyrer, Jochen Senges, Kenneth J. Rothman

Article2022

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry

Valentina Bayer, Agnieszka Kotalczyk, Bory Kea, Christine Teutsch, Peter Larsen, Dana Button, Menno V. Huisman, Professor Gregory Lip, Brian Olshansky

Article2021

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF

Monika Kozieł, Christine Teutsch, Jonathan L. Halperin, Kenneth J. Rothman, Hans‐Christoph Diener, Chang-Sheng Ma, Sabrina Marler, Shihai Lu, Venkatesh Kumar Gurusamy, Menno V. Huisman, Professor Gregory Lip

Article2023

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Xiaoxia Liu, Guoze Feng, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip, Changsheng Ma

Article2025

Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Menno V. Huisman, Professor Gregory Lip